Replication study for reported SNP associations with breast cancer survival

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 6, 2012, Pages 1019-1026

  Beeghly Fadiel, Alicia ^a   Zheng, Wei ^a   Lu, Wei ^b   Long, Jirong ^a   Zheng, Ying ^b   Cai, Hui ^a   Gu, Kai ^b   Chen, Zhi ^a   Cai, Qiuyin ^a   Gao, Yu Tang ^c   Shu, Xiao Ou ^a,d  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c SHANGHAI CANCER INSTITUTE   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Genetic variants; Matrix metalloproteinases; Replication; Survival

Indexed keywords

CATECHOL METHYLTRANSFERASE; MACROPHAGE ELASTASE; MATRILYSIN; NEUTROPHIL COLLAGENASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CASE CONTROL STUDY; CCND1 GENE; COMT GENE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MMP12 GENE; MMP7 GENE; MMP8 GENE; OVERALL SURVIVAL; PRIORITY JOURNAL; REPLICATION STUDY; SERPINE1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TGFB1 GENE; VEGFA GENE;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 84864368107     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1174-6     Document Type: Article

References (24)

1. Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM et al (2009) Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival. Clin Cancer Res 15:2181-2191
2. Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, Sweeney C et al (2005) Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 65:1105-1111
3. Azzato E, Driver K, Lesueur F, Shah M, Greenberg D, Easton D et al (2008) Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast Cancer Res 10:R47
4. Beeghly-Fadiel A, Long JR, Gao YT, Li C, Qu S, Cai Q et al (2008) Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Cancer Res 68:6453-6459
5. Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai H et al (2009) Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Int J Cancer 124:208-214
6. Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W et al (2007) Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res 67:10214-10221
7. Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR et al (2008) Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis. BMC Cancer 8:77
8. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174
9. Hojilla CV, Mohammed FF, Khokha R (2003) Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89:1817-1821
10. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD et al (2005) Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 11:6012-6019
11. Knechtel G, Hofmann G, Gerger A, Renner W, Langsenlehner T, Szkandera J et al (2010) Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. J Cancer Res Clin Oncol 136: 1813-1819
12. Long JR, Cai Q, Shu XO, Cai H, Gao YT, Zheng W (2007) Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Pharmacogenet Genomics 17:331-338
13. Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q et al (2005) Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 65:5015-5019
14. Martin M, Matrisian L (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26:717-724
15. Saarialho-Kere UK, Crouch EC, Parks WC (1995) Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 105:190-196
16. Shin A, Cai Q, Shu XO, Gao YT, Zheng W (2005) Genetic polymorphisms in the matrix metalloproteinase 12 gene (MMP12) and breast cancer risk and survival: the Shanghai breast cancer study. Breast Cancer Res 7:R506-R512
17. Shu XO, Gao YT, Cai Q, Pierce L, Cai H, Ruan ZX et al (2004) Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai breast cancer study. Cancer Res 64:836-839
18. Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L et al (2005) Association of Cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev 14:91-97
19. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W et al (2009) Soy food intake and breast cancer survival. JAMA J Am Med Assoc 302:2437-2443
20. Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209-213
21. Udler MS, Azzato EM, Healey CS, Ahmed S, Pooley KA, Greenberg D et al (2009) Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer. Int J Cancer 125:2687-2696
22. Wilson CL, Matrisian LM (1996) Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28:123-136
23. Zhang X, Shu XO, Cai Q, Ruan Z, Gao YT, Zheng W (2006) Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival. Clin Cancer Res 12:6037-6042
24. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB et al (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41:324-328